Sat 18 October 2025
Warszawa (PL)
10/6°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 11 | 12 | 8 | 9 | 8 |
Sat 18 October 2025
Praha (CZ)
10/5°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 14 | 14 | 10 | 11 | 12 |
Sat 18 October 2025
Bratislava (SK)
9/7°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 16 | 16 | 12 | 12 | 12 |
Sat 18 October 2025
Budapest (HU)
10/8°C
| Thu | Fri | Sat | Sun | Mon |
|---|---|---|---|---|
| 16 | 17 | 13 | 13 | 13 |
State drugs authority recommends anti-COVID drug from Regeneron
February 16th, 2021
The Czech State Drugs Control Institute (SUKL) recommended an anti-coronavirus drug by the Regeneron company to be used in Czechia even though it has not been registered yet, SUKL director Irena Storova tweeted today. The drug is based on a combination of two monoclonal antibodies, Casirivimab and Imdevimab. It is meant for high-risk outpatients. A week ago, the SUKL recommended the first monoclonal-based drug from the U.S. Eli Lilly firm and its usage was approved by the Health Ministry, too, some days after.
CTK